'Low dose' diaporamas de présentation

Optimizing the choice in oral contraception

PANELISTS. Optimizing the choice in oral contraception. Dr Asha Bhatt Dr Dipti Patel Dr Bharat Rangani Dr Tejal Shah Dr Pooja Nadkarni. Case 1. A newly married girl comes to you for information about contraception.

1.31k views • 95 slides

Improving Control in Severe Asthma

1.08k views • 64 slides

CANCER

CANCER. Cancer. Statistics Second leading cause of death 1 in 3 will develop cancer, 1 in 5 will die Approx. 556,500 Americans die each year from cancer Approx. 1.3 million will be diagnosed with cancer African Americans have the highest mortality rates of cancer

1.16k views • 60 slides

Daniel Berg M.D., FRCPC Director Dermatologic Surgery Professor, Dermatology University of Washington

961 views • 54 slides

Protection against Exposure to Low-dose Radiation :

600 views • 51 slides

The Future of Radiation Protection An IRPA Perspective

HERCA Meeting, Liverpool, May 2019. The Future of Radiation Protection An IRPA Perspective. Roger Coates, IRPA President. Role of IRPA T he international voice of RP professionals. 52 Associate Societies Representing 67 countries Over 18,000 individual members.

688 views • 49 slides

The combination of low dose of naloxone and morphine in PCA

The combination of low dose of naloxone and morphine in PCA. 10/4 Morning Meeting Yu Chang Yeh. The combination of low dose of naloxone and morphine in PCA. Objective Backgrounds Patient selection and exclusion Standard setup. The combination of low dose of naloxone and morphine in PCA.

656 views • 45 slides

Primary Adrenal Disease

Primary Adrenal Disease. Briana Patterson, M.D. Fellow, Pediatric Endocrinology Emory University School of Medicine. Objectives. Normal adrenal physiology Common causes of primary adrenal insufficiency Evaluation of suspected adrenal insufficiency Acute and chronic management issues.

1.31k views • 44 slides

Kehinde M.O 1 ., Ogungbemi S.I 2 ., Anigbogu C.N 2 ., and Jaja S.I 2 .

L-ARGININE SUPPLEMENTATION ENHANCES ANTIOXIDANT ACTIVITY AND ERYTHROCYTE INTEGRITY IN SICKLE CELL ANEMIA SUBJECTS. Kehinde M.O 1 ., Ogungbemi S.I 2 ., Anigbogu C.N 2 ., and Jaja S.I 2 . 1 Department of Medicine, 2 Department of Physiology,

1.77k views • 41 slides

659 views • 40 slides

WALTER REED JOURNAL CLUB

515 views • 38 slides

EARLY NONSTOCHASTIC EFFECTS/LATE STOCHASTIC EFFECTS

EARLY NONSTOCHASTIC EFFECTS/LATE STOCHASTIC EFFECTS. Sherer Chapter 6, Reference: Bushong, Chapter 36 and 37 . Review of Dose response curves. Threshold Non threshold Linear quadratic non threshold curve Non linear (s-shaped or sigmoid) . Early, Nonstochastic Effects:.

707 views • 34 slides

The Right to Refuse Treatment

The Right to Refuse Treatment. Brenda Keller, M.D. Thomas Magnuson, M.D. Objectives. Elucidate the concept of informed consent Define power of attorney and guardianship Discuss refusal of treatment issues Describe how to proceed with an evaluation. Case One. Refusal of medication

1.49k views • 25 slides

Tasks for the ECT team

Tasks for the ECT team. Dr Grace Fergusson Argyll and Bute Hospital Lochgilphead Royal College of Psychiatrists ECT training day, January 2002. The ECT consultant. Advice and liason Treatment policy Training Supervision. Advice and Liason. ECT suite and equipment Staffing Liason

705 views • 24 slides

HRT

HRT. In a nutshell for all the blokes out there. diagnosis. Clinical hx FSH limited value as levels fluctuate May be of value in symtomatic women under 40y FSH >30. Also. Lifestyle Smoking Alcohol Exercise caffeine. indications. Early menopause (<45yrs)

403 views • 23 slides

Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology

Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology. Barbara Hill, Ph.D. Division of Dermatologic and Dental Drug Products. Pediatric Advisory Committee Meeting February 15, 2005. Objective.

713 views • 20 slides

2009 Revisions of WHO recommendations on use of Antiretroviral Therapy (ART)

458 views • 18 slides

Drug Use and Hepatitis C Are we mindful of the gaps? Dave Liddell, SDF

335 views • 15 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. Immunogens Or Antigens. Immunogens or Antigen s. Immunogen or antigen: * A foreign substance, when introduced into human body, stimulate formation of specific antibodies or sensitized lymphocytes * Antigens have the ability to combine

737 views • 14 slides

Hormone Replacement Therapy - Pipeline Analysis to 2016

The Hormone Therapy Drugs Market is Forecast to Show Marginal Growth Until 2016

467 views • 4 slides